U.S. FDA approves Boehringer’s JASCAYD® (nerandomilast tablets) as first new treatment option for adults with IPF in over a decade

FDA approves new obesity drug

FDA Academy - Food and Drug Administration

FDA cGMP Training Program - SlideServe

Compliance Training 101: All You Wanted to Know

Glowing neon FDA Approved icon Food and Drug Administration label. FDA Approved blue Check Mark icon. FDA Approval icon and Medical Research, Healthcare Regulation and Pharmaceutical Process

The Food and Drug Administration has reversed course and will now consider whether to approve a new flu shot from Moderna that uses mRNA technology. The new development comes a week after the FDA rejected the company's initial application, saying its research design was flawed. Moderna is now seeking full approval for the vaccine's use in adults aged 50 to 64 and what's called accelerated approval for those 65 and older. The company says the FDA set an August deadline for approval. Moderna hopes

The Hill's Weekend Headlines u2014 Nov. 28 - 30